“…TGFβ2 knockout mice have cardiac, lung, craniofacial, limb, spinal column, eye, inner ear, and urogenital defects [Sanford et al, 1997], whereas the TGFβ1 knockout mice exhibit an autoimmune-like inflammatory disease or embryonic lethality due to defective yolk sac hematopoiesis and vasculogenesis, depending on the genetic background [Dickson et al, 1995; Kulkarni et al, 1993; Shull et al, 1992]. Consistent with the results from these mouse models, there is a specific requirement for TGFβ2, but not TGFβ1, to rescue the phenotype of RUNX1 depletion in hESCs [VanOudenhove et al, In Press, 2016]. …”